Table: begin end state 1 5 non-cytoplasmic 6 29 transmembrane 30 36 cytoplasmic 37 106 non-cytoplasmic 107 125 transmembrane 126 130 cytoplasmic 131 150 transmembrane 151 155 non-cytoplasmic 156 179 transmembrane 180 190 cytoplasmic 191 197 non-cytoplasmic 198 199 cytoplasmic 200 227 transmembrane 228 278 cytoplasmic 279 305 transmembrane 306 310 non-cytoplasmic 311 330 transmembrane 331 357 cytoplasmic 358 378 transmembrane 379 412 non-cytoplasmic 413 419 transmembrane 420 424 non-cytoplasmic 425 443 transmembrane 444 448 cytoplasmic 449 467 transmembrane 468 472 non-cytoplasmic 473 497 transmembrane 498 502 cytoplasmic 503 528 transmembrane 529 532 non-cytoplasmic 533 552 transmembrane 553 587 cytoplasmic 588 611 transmembrane 612 630 non-cytoplasmic 631 649 transmembrane 650 664 cytoplasmic
Input: >GFF2296 FitnessBrowser__Phaeo:GFF2296 MSARLSPQSATVWGLILVTILLGWFGRDLSKALDARWLIKVPSSWVLPLKGHISSAMTWL VEDAAIGPISFTDVTRAVAWLIEQPYELMLSLLANGFFVSSGPGAEALLPAASWIAVTAA VIALGHYCRNWGLAAVAGACFAYLAVFGQWDSAMVTLASVLIAVPIGAGGGLLTGIWAYR HPVGERILSPLLDLMQTIPIFAYLVPILFMFGFGPVSALVATIIYATPPMIRVTILALKS VDPEILDFGRMAGTTPRQLMWRVLVPSASQSLMVGVNQVIMLTLNMVIIASMIGAGGLGF DVLAALRRLDIGAGFEAGIAIVVLAIAVDRLSQAFAERMGQVHHIAPGSKATRHKRTVLV LSLLIITWGLGRFSPLLLQYPISQTITTGDFWSETVKYLNVNYFDAFEAVKVFFLHWFML PIKKTLLGIPWPWAVAMLTLVGWRAGGLRLALMCGSMSTLIAFSGLWAKAMVTVYLCGAS VILATLIGVPLGVLAALNKRAGVAIGLFIDTLQTLPSFVYLIPVVMLFRVGDFTAMIAIV LYALAPAVRYAAHGMRSVSGELIEAGLVSGCTRWQLLRMVRLPMALPEILLGINQTIMLA LSMLVITALVGTRDLGQEVYIALTKADTGRGLVAGLAIAFIAIIADRLVNAGARGARIRF GLET
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server